Loading...
Safety and Tolerability of ACP-501, a Recombinant Human Lecithin:Cholesterol Acyltransferase, in a Phase 1 Single-Dose Escalation Study
RATIONALE: Low high-density lipoprotein cholesterol (HDL-C) in coronary heart disease (CHD) patients may be due to rate-limiting amounts of lecithin:cholesterol acyltransferase (LCAT). Raising LCAT may be beneficial for CHD, as well as for Familial LCAT Deficiency (FLD), a rare disorder of low HDL-C...
Na minha lista:
| Udgivet i: | Circ Res |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4740220/ https://ncbi.nlm.nih.gov/pubmed/26628614 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCRESAHA.115.306223 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|